Sarcoma
MONDO:0005089A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.
Also known as: mesenchymal tumor, malignant, sarcoma, sarcoma of soft tissue and bone, sarcoma of the soft tissue and bone, sarcoma, malignant, tumor of soft tissue and skeleton, tumour of soft tissue and skeleton
3676 clinical trials for this condition and its sub-types, 493 tagged with Sarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Sarcoma
-
Soft tissue sarcoma 296 trials · 645 incl. sub-types
46 sub-types
- Rhabdomyosarcoma 99 trials · 113 incl. sub-types Sub-types →
- Liposarcoma 58 trials · 83 incl. sub-types Sub-types →
- Angiosarcoma 37 trials · 82 incl. sub-types Sub-types →
- Rhabdoid tumor 63 trials · 75 incl. sub-types Sub-types →
- Central nervous system sarcoma 2 trials · 74 incl. sub-types Sub-types →
- Leiomyosarcoma 62 trials · 72 incl. sub-types Sub-types →
- Synovial sarcoma 53 trials Sub-types →
- Undifferentiated pleomorphic sarcoma 48 trials Sub-types →
- Desmoplastic small round cell tumor 26 trials
- Fibrosarcoma 9 trials · 21 incl. sub-types Sub-types →
- Myxofibrosarcoma 21 trials
- Alveolar soft part sarcoma 20 trials Sub-types →
- Epithelioid sarcoma 20 trials Sub-types →
- Retroperitoneal sarcoma 17 trials Sub-types →
- Clear cell sarcoma 14 trials · 16 incl. sub-types Sub-types →
- Liver sarcoma 1 trial · 10 incl. sub-types Sub-types →
- Skin sarcoma 1 trial · 9 incl. sub-types Sub-types →
- SMARCA4-deficient sarcoma of thorax 8 trials
- Kidney sarcoma 0 trials · 8 incl. sub-types Sub-types →
- Extraskeletal myxoid chondrosarcoma 7 trials Sub-types →
- Intimal sarcoma 4 trials
- Breast sarcoma 2 trials · 3 incl. sub-types Sub-types →
- Extraskeletal Ewing sarcoma 3 trials
- Undifferentiated round cell sarcoma 3 trials
- Extraosseous osteosarcoma 2 trials Sub-types →
- Ovarian sarcoma 0 trials · 2 incl. sub-types Sub-types →
- Heart sarcoma 1 trial Sub-types →
- Small intestinal sarcoma 0 trials · 1 incl. sub-types Sub-types →
- Testis sarcoma 0 trials · 1 incl. sub-types Sub-types →
- Anus sarcoma 0 trials Sub-types →
- Bladder sarcoma 0 trials
- Esophagus sarcoma 0 trials Sub-types →
- Gallbladder sarcoma 0 trials Sub-types →
- Laryngeal sarcoma 0 trials Sub-types →
- Lung sarcoma 0 trials Sub-types →
- Mediastinum sarcoma 0 trials Sub-types →
- Myxosarcoma 0 trials
- Pancreas sarcoma 0 trials
- Paranasal sinus sarcoma 0 trials
- Penile sarcoma 0 trials
- Prostate sarcoma 0 trials Sub-types →
- Stromal sarcoma 0 trials Sub-types →
- Thyroid sarcoma 0 trials Sub-types →
- Trachea sarcoma 0 trials
- Vagina sarcoma 0 trials Sub-types →
- Vulva sarcoma 0 trials Sub-types →
-
Osteosarcoma 169 trials · 173 incl. sub-types
6 sub-types
- Localized osteosarcoma 13 trials
- Bone osteosarcoma 8 trials Sub-types →
- Pediatric osteosarcoma 8 trials Sub-types →
- Extraosseous osteosarcoma 2 trials Sub-types →
- Low grade central osteosarcoma 0 trials
- Multifocal osteogenic sarcoma 0 trials Sub-types →
-
Ewing sarcoma 124 trials · 125 incl. sub-types
2 sub-types
- Ewing sarcoma of bone 5 trials
- Extraskeletal Ewing sarcoma 3 trials
-
Bone sarcoma 41 trials · 108 incl. sub-types
13 sub-types
- Undifferentiated pleomorphic sarcoma 48 trials Sub-types →
- Dedifferentiated chondrosarcoma 9 trials
- Bone giant cell tumor 7 trials · 8 incl. sub-types Sub-types →
- Bone osteosarcoma 8 trials Sub-types →
- Ewing sarcoma of bone 5 trials
- Undifferentiated high grade pleomorphic sarcoma of bone 4 trials
- Clear cell chondrosarcoma 3 trials
- Malignancy in giant cell tumor of bone 1 trial
- Bone angiosarcoma 0 trials
- Bone fibrosarcoma 0 trials
- Bone leiomyosarcoma 0 trials
- Liposarcoma of bone 0 trials
- Periosteal chondrosarcoma 0 trials
-
Dendritic cell sarcoma 0 trials · 53 incl. sub-types
3 sub-types
- Interdigitating dendritic cell sarcoma 53 trials
- Follicular dendritic cell sarcoma 2 trials
- Langerhans cell sarcoma 0 trials
-
Chondrosarcoma 39 trials · 44 incl. sub-types
4 sub-types
- Bone chondrosarcoma 1 trial · 10 incl. sub-types Sub-types →
- Mesenchymal chondrosarcoma 4 trials Sub-types →
- Myxoid chondrosarcoma 2 trials Sub-types →
- Localized chondrosarcoma 0 trials
-
Small cell sarcoma 0 trials · 37 incl. sub-types
6 sub-types
- Desmoplastic small round cell tumor 26 trials
- EWSR1-negative small round cell tumor 0 trials · 5 incl. sub-types Sub-types →
- Mesenchymal chondrosarcoma 4 trials Sub-types →
- Round cell sarcoma with EWSR1-non-ETS fusion 2 trials Sub-types →
- Sarcoma with BCOR genetic alterations 1 trial · 2 incl. sub-types Sub-types →
- Small cell osteogenic sarcoma 0 trials
-
Myeloid sarcoma 27 trials
1 sub-type
- Granulocytic sarcoma 0 trials
-
Uterine corpus sarcoma 12 trials · 19 incl. sub-types
3 sub-types
- Leiomyosarcoma of the corpus uteri 9 trials Sub-types →
- Uterine corpus endometrial stromal sarcoma 0 trials
- Uterine corpus rhabdomyosarcoma 0 trials
-
Spindle cell sarcoma 6 trials · 13 incl. sub-types
4 sub-types
- Intimal sarcoma 4 trials
- Spindle cell rhabdomyosarcoma 3 trials Sub-types →
- Spindle cell liposarcoma 0 trials
- Spindle cell synovial sarcoma 0 trials
-
Endometrioid stromal sarcoma 2 trials
3 sub-types
-
Ectomesenchymoma 1 trial
-
Giant cell tumor of soft tissue 1 trial
-
Sarcomatosis 1 trial
1 sub-type
- Sarcomatosis of the meninges 0 trials
-
Colon sarcoma 0 trials
2 sub-types
- Colon Kaposi sarcoma 0 trials
- Colon leiomyosarcoma 0 trials
-
Lymphangiosarcoma 0 trials
1 sub-type
- Skin lymphangiosarcoma 0 trials
-
Mast cell sarcoma 0 trials
-
Orbit sarcoma 0 trials
1 sub-type
- Orbit rhabdomyosarcoma 0 trials Sub-types →
-
Rectum sarcoma 0 trials
4 sub-types
- Anus sarcoma 0 trials Sub-types →
- Rectum Kaposi sarcoma 0 trials
- Rectum leiomyosarcoma 0 trials Sub-types →
- Rectum rhabdomyosarcoma 0 trials Sub-types →
-
Reticulum cell sarcoma 0 trials
-
Sarcoma G1 0 trials
-
Sarcoma of cervix uteri 0 trials
5 sub-types
Most studied deeper sub-types
-
Custom-Made antibodies could turn the Body's own defenses against cancer
Cure Not yet recruitingThis early-stage trial is testing whether antibodies created in a lab from a patient's own tumor can help the immune system attack and kill cancer cells. The antibodies are designed to target specific markers on cancer cells that are not found on healthy cells. Participants with …
Phase 1 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Cure
Last updated Aug 27, 2026 00:00 UTC
-
Can a Dual-Target drug crack resistant gynecologic and breast cancers?
Disease control Not yet recruitingResearchers are testing an oral drug called AL58805, which blocks two cancer-growth proteins, PI3K and mTOR, in adults with advanced endometrial, cervical, soft tissue sarcoma, or breast cancers that have worsened after at least one standard treatment. Participants receive AL5880…
Phase 1/2 • Sponsor: Advenchen Pharmaceuticals, LLC. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can an oral drug that starves tumors help Hard-to-Treat cancers?
Disease control Not yet recruitingResearchers are testing an investigational oral drug called catequentinib hydrochloride (AL3818) in adults with advanced or metastatic endometrial cancer, low grade serous ovarian cancer, soft tissue sarcoma, or glioblastoma. The trial has two parts: a phase 1b part to find safe …
Phase 1/2 • Sponsor: Advenchen Pharmaceuticals, LLC. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a coordinated care team reduce severe side effects in older cancer patients?
Disease control Not yet recruitingThis trial tests whether a coordinated care pathway, involving oncologists, geriatricians, pharmacists, and pharmacologists, can reduce severe side effects in adults over 70 with certain cancers who are starting oral therapy. Participants receive extra monitoring, including blood…
Phase 4 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a smart drug hunt down sarcoma cells without harming healthy ones?
Disease control Not yet recruitingThis trial tests SOT106, a cancer medicine designed to find and kill cells that carry a marker called LRRC15, which appears on some osteosarcoma and soft tissue sarcoma tumors. The study has two parts: the first finds safe dose levels, and the second compares two doses to see whi…
Phase 1/2 • Sponsor: SOTIO Biotech a.s. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat sarcomas
Disease control Not yet recruitingThis early-stage trial is testing a combination of specially engineered immune cells (CAR T cells) and a vaccine for people with sarcoma that has come back or spread. The goal is to see if the treatment is safe and can help shrink tumors. About 20 participants will receive the th…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat sarcomas
Disease control Not yet recruitingThis trial tests a 4th-generation safety-engineered CAR T cell therapy for people with relapsed or late-stage sarcomas, including osteosarcoma and Ewing sarcoma. Participants receive a single infusion of these immune cells designed to target and attack sarcoma cells. The study ai…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Patient's own immune cells fight advanced sarcoma?
Disease control Not yet recruitingThis phase 2 trial is testing whether lifileucel, a therapy made from a patient's own tumor-infiltrating lymphocytes (immune cells), can shrink tumors in adults with advanced soft tissue sarcoma. Participants will have their tumor removed to create the personalized therapy, then …
Phase 2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Sarcoma surgery debate: can skipping biopsy track removal reduce harm without raising recurrence risk?
Disease control Not yet recruitingThis study tests whether leaving the needle biopsy track in place during sarcoma surgery is as safe as removing it. The goal is to see if avoiding extra tissue removal can lower complications without increasing the chance of the cancer coming back. About 3,300 people with sarcoma…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden sarcoma tumors in Children's lungs
Disease control Not yet recruitingThis pilot study tests whether a dye called TumorGlow (indocyanine green) can help surgeons see and remove sarcoma tumors that have spread to the lungs in children aged 12 to 17. The dye is given intravenously up to five days before surgery, and during the operation, a special ca…
Early phase 1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo aims to fight rare sarcoma
Disease control Not yet recruitingThis Phase 2 trial tests two drugs, OVV-01 and AK112, given together every two weeks to 40 adults with advanced soft tissue sarcoma that has not responded to standard treatments. The main goal is to see if the combination can shrink tumors safely. Researchers will also measure ho…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a saffron-derived compound boost radiation for sarcoma?
Disease control Not yet recruitingThis phase 2 trial tests whether adding a drug called liposomal transcrocetin (L-TC) to short-course radiation before surgery can kill more cancer cells in people with soft-tissue sarcoma. About 42 adults with localized or locally advanced sarcoma will be randomly assigned to rec…
Phase 2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could adding immunotherapy to Pre-Sarcoma treatment boost survival?
Disease control Not yet recruitingThis study looks at whether adding an immunotherapy drug (penpulimab) to standard pre-surgery radiation and a targeted therapy (anlotinib) can help people with soft tissue sarcoma live longer without the cancer coming back. About 274 adults with intermediate- to high-grade sarcom…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Iron nanoparticles could supercharge radiation against cancer
Disease control Not yet recruitingThis Phase 2 trial tests an experimental iron nanoparticle injection (CNSI-Fe) given directly into tumors along with standard radiotherapy. The goal is to see if the combination shrinks tumors better than radiation alone. The study will enroll 52 adults with head and neck cancer …
Phase 2 • Sponsor: Sichuan Enray Pharmaceutical Sciences Company • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug cocktail aims to halt sarcoma progression
Disease control Not yet recruitingThis phase 2 trial tests a combination of three drugs—liposomal irinotecan, temozolomide, and bevacizumab—in 24 people with soft tissue sarcoma that has returned or not responded to prior treatment. The goal is to see if the combination can slow or stop tumor growth. Participants…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New combo therapy aims to improve sarcoma surgery outcomes
Disease control Not yet recruitingThis trial is testing whether giving a special type of radiation (ultra-hypofractionated) along with immunotherapy before surgery is safe and feasible for people with retroperitoneal sarcoma. The study will enroll 28 participants. The main goal is to see how many patients have co…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a nose ointment and body wash prevent surgery wounds from getting worse?
Disease control Not yet recruitingThis study tests if using a nose ointment and body wash before and during radiation, plus a special dye during surgery, can lower the chance of serious wound problems. About 31 people with soft tissue sarcoma in the leg will take part. The goal is to see if these low-cost steps h…
Phase 2 • Sponsor: Adam Olson • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New combo therapy aims to tackle tough sarcomas
Disease control Not yet recruitingThis phase 2 trial is testing a new treatment for soft tissue sarcoma that combines a special type of radiation with immunotherapy and immune-boosting drugs. The goal is to see if this combination can shrink tumors and improve outcomes for people with advanced or recurrent sarcom…
Phase 2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Experimental drug combo takes on rare sarcomas
Disease control Not yet recruitingThis early-phase trial tests a new drug called BOLD-100 combined with standard chemotherapy (doxorubicin) in 32 people with advanced soft tissue sarcomas that cannot be removed by surgery or have spread. The goal is to find the safest dose and see if the combination can shrink tu…
Phase 1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New radiation approach aims to improve sarcoma surgery outcomes
Disease control Not yet recruitingThis study tests a new type of radiation called carbon ion radiotherapy given before surgery for soft tissue sarcoma. The goal is to see if it is safe and can reduce wound problems after surgery while better controlling the tumor. About 60 adults with sarcoma that can be removed …
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New cocktail of drugs and radiation targets Hard-to-Treat sarcoma
Disease control Not yet recruitingThis phase 2 trial tests a combination of the immunotherapy epalrotokewali, chemotherapy eribulin, targeted therapy anlotinib, and radiotherapy in 46 people with advanced soft tissue sarcoma that has progressed after prior treatment. The goal is to see if this mix can shrink tumo…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Green dye could help surgeons spot hidden cancer in kids
Diagnosis Not yet recruitingThis study tests whether a green dye called indocyanine green (ICG) can help surgeons find sentinel lymph nodes—the first nodes where cancer might spread—in children with solid tumors. Ten children under 18 will get the dye injected during surgery, and doctors will check if it li…
Sponsor: University of Rochester • Aim: Diagnosis
Last updated Aug 28, 2026 00:00 UTC
-
New MRI technique could slash radiation in bone cancer surgeries
Diagnosis Not yet recruitingThis study tests whether a special MRI sequence, called 'pseudo-scanner,' can accurately map bone tumors and guide surgery, potentially replacing CT scans. About 122 people with bone sarcoma who need surgery will participate. If successful, this approach could reduce patients' ex…
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
Could early palliative care reduce aggressive End-of-Life cancer treatments?
Symptom relief Not yet recruitingThis study looks at whether bringing in palliative care early during an unplanned hospital stay can reduce aggressive treatments at the end of life for people with advanced cancer. About 493 adults with metastatic digestive, gynecological, ENT, or sarcoma cancers will be randomly…
Sponsor: Centre Oscar Lambret • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Pedaling through chemo: could exercise boost tumor blood flow?
Symptom relief Not yet recruitingThis trial tests whether doing light-to-moderate aerobic exercise during chemotherapy infusions is safe and practical for people with sarcoma (a type of cancer). Participants will exercise in 15-minute intervals during each infusion, and researchers will also check if exercise te…
Sponsor: Kira Bloomquist • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Smartwatch exercise plan aims to rebuild fitness in young cancer survivors
Symptom relief Not yet recruitingThis trial tests whether a personalized, smartwatch-supported home exercise program can increase physical activity and improve heart health, mobility, and quality of life in adolescents and young adults who have survived bone or soft tissue sarcoma. Participants wear a fitness tr…
Sponsor: Universität Duisburg-Essen • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Hypnosis may ease chemo anxiety in teens and young adults
Symptom relief Not yet recruitingThis study tests whether a single hypnosis session during chemotherapy can reduce anxiety and other side effects like nausea in young people with cancer. It includes 70 participants aged 15-49 with sarcoma, germ cell tumors, or breast cancer. Researchers will compare anxiety leve…
Sponsor: Institut Bergonié • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a simple salt water soak ease radiation skin pain?
Symptom relief Not yet recruitingThis study tests whether daily soaks with normal saline (salt water) can reduce severe skin reactions caused by radiation therapy. About 150 adults with head and neck cancer or sarcoma will either get standard care or standard care plus a 5-10 minute saline soak each day. Researc…
Sponsor: King Hussein Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Acupuncture may cut hospital time for chemo patients
Symptom relief Not yet recruitingThis study tests whether adding acupuncture to standard care can lower the risk of hospital stays for a serious chemo side effect called febrile neutropenia (fever with low white blood cells). About 60 adults with sarcoma receiving doxorubicin chemotherapy will be randomly assign…
Sponsor: Shaare Zedek Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
AI chatbot aims to ease anxiety for sarcoma patients
Symptom relief Not yet recruitingThis study is testing a new AI chatbot designed to answer questions from people with sarcoma, a type of cancer. The chatbot will be available 24/7 by voice or text for one month. Researchers want to see if using the chatbot helps patients feel more satisfied with the information …
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Sound waves vs. tumors: new device aims to zap pain without surgery
Symptom relief Not yet recruitingThis study tests a device called histotripsy, which uses focused ultrasound to break up tumors without cutting the skin. It is for people with abdominal tumors that cannot be surgically removed and are causing symptoms like pain. The goal is to see if the treatment improves quali…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 17:36 UTC
-
Glow-in-the-dark dye may help surgeons spot sarcoma during removal
Knowledge-focused Not yet recruitingThis early-stage study tests whether a fluorescent dye called 5-ALA can make soft-tissue sarcoma tumors glow during surgery, helping surgeons see the edges more clearly. About 20 adults with grade 2 or 3 sarcoma will take the dye by mouth before their standard surgery. The main g…
Early phase 1 • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Immunotherapy may change how your body processes other drugs
Knowledge-focused Not yet recruitingThis study will test whether immunotherapy drugs (immune checkpoint inhibitors) change how the liver processes other medications. About 80 adults with various cancers who are starting immunotherapy will take a low-dose cocktail of 7 common drugs. Researchers will measure drug lev…
Early phase 1 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
New app guides young cancer survivors through life after treatment
Knowledge-focused Not yet recruitingThis study is testing a mobile app called my.naviGATE for teens and young adults (ages 15-24) who have finished cancer treatment. The app provides personalized education, peer support, and tracks how patients are doing. Researchers want to see if the app helps patients feel more …
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Tiny study checks if extra MRIs during sarcoma radiation are doable
Knowledge-focused Not yet recruitingThis very small study will test whether it is practical to add three extra MRI scans during standard radiation treatment for soft tissue sarcoma. Only 5 adults will take part. The goal is simply to see if the extra scans can be completed, not to change treatment or improve outcom…
Sponsor: Andrew Frankart • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New blood test could spot sarcoma cells early
Knowledge-focused Not yet recruitingThis study aims to create a new method to find and sort cancer cells that float in the blood of people with advanced soft tissue sarcoma. Researchers will collect blood and tumor samples from 100 adults to develop this detection technique. The goal is to better understand the dis…
Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC